Cargando…
Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
BACKGROUND: The first line treatment for Chagas disease, a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi, involves administration of benznidazole (Bzn). Bzn is a 2-nitroimidazole pro-drug which requires nitroreduction to become active, although its mode of action is n...
Autores principales: | Trochine, Andrea, Creek, Darren J., Faral-Tello, Paula, Barrett, Michael P., Robello, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031082/ https://www.ncbi.nlm.nih.gov/pubmed/24853684 http://dx.doi.org/10.1371/journal.pntd.0002844 |
Ejemplares similares
-
New Insights into the Role of the Trypanosoma cruzi Aldo-Keto Reductase TcAKR
por: Díaz-Viraqué, Florencia, et al.
Publicado: (2023) -
Maxicircle architecture and evolutionary insights into Trypanosoma cruzi complex
por: Berná, Luisa, et al.
Publicado: (2021) -
Early Trypanosoma cruzi Infection Triggers mTORC1-Mediated Respiration Increase and Mitochondrial Biogenesis in Human Primary Cardiomyocytes
por: Libisch, M. Gabriela, et al.
Publicado: (2018) -
Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain
por: Fonseca, Kátia da Silva, et al.
Publicado: (2021) -
Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations
por: Lima, Davi Alvarenga, et al.
Publicado: (2023)